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Abstract Microscopic visualization of intracellular enzyme
activity can provide information about the physiological role of
the enzyme. Caspases are cysteine proteases that have critical
roles in the execution of apoptosis. General fluorometric
substrates of caspase-3, such as DEVD-MCA, are unsuitable
for imaging because they are excited at short wavelength, so we
designed and synthesized novel fluorescent probes that are
excited at suitable wavelengths for detecting caspase-3 activity
in living cells. Using one of these probes, we succeeded in
microscopic visualization of caspase-3-like activity within HeLa
cells treated with etoposide. The caspase-3-like activity was
increased in the cytosol at first, then expanded to the whole cell.
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1. Introduction
Apoptosis is a form of cell death that is accompanied by
characteristic changes in the cell, such as chromatin conden-
sation, formation of apoptotic bodies, DNA degradation, etc.
Cysteine proteases called caspases play important roles in
apoptosis. Nicholson et al. classi¢ed caspases into three
groups according to their substrate speci¢city [1]. Among
these groups, the group II caspases (caspase-2, -3 and -7),
whose preferred tetrapeptide sequence for cleavage is DEXD
(X is an unspeci¢ed amino acid), are reported to cleave several
apoptosis-related proteins, for instance poly-ADP-ribose pol-
ymerase (PARP) [2], which is involved in DNA repair, ge-
nome surveillance and integrity [3,4]. Caspase-3 is also re-
quired for DNase activation [5].
Microscopic visualization of caspase-3-like activities in cells
would provide valuable information about the apoptotic
mechanism. However, DEVD-MCA and its derivatives [6],
which are generally used to detect caspase-3-like activities,
can only be used in cell-free systems, because DEVD-MCA
is excited at 380 nm and auto£uorescence of cells excited at
around 380 nm interferes with measurements. In this report,
we describe the design and synthesis of novel £uorescent
probes to allow direct visualization of caspase-3-like activity
in cells. These probes are excited at long wavelength, so cel-
lular auto£uorescence is suppressed. We used one of the
probes to visualize the activities of caspase-3-like proteases
in HeLa-S3 cells during the induction of apoptosis by treat-
ment with etoposide.
2. Materials and methods
2.1. Materials
Ac-DEVD-MCA and Z-Asp-CH2-DCB were purchased from Pep-
tide Institute (Osaka, Japan). Recombinant human caspase-1 was
kindly donated by Dr. D.W. Nicholson. Recombinant human casp-
ase-3 was purchased from Funakoshi (Tokyo, Japan). Recombinant
human caspase-6 and caspase-7 were purchased from Pharmingen
(San Diego, CA, USA). Etoposide was purchased from Sigma (St.
Louis, MO, USA). All double-labeled peptides and DEVD-MCA
were stored at 320‡C as 200 WM stock DMSO solutions. Protease
assay (PA) bu¡er contains 20 mM HEPES (pH 7.5), 10 mM dithio-
threitol, 10% glycerol, 0.1% CHAPS, and 100 mM NaCl.
2.2. Synthesis of double-labeled peptides
We applied a method developed by Geoghegan et al. [7,8], using
periodate oxidation of N-terminal serine. SGDEVDGVK (Peptide
Institute; 1.1 mg, 1.0 Wmol) was dissolved in 25 mM sodium phos-
phate bu¡er (pH 7.0). This solution was treated with 30 Wl of 40 mM
NaIO4 in 25 mM sodium phosphate bu¡er (pH 7.0) for 30 min. Then,
120 Wl of 30 mM lucifer yellow CH dipotassium salt (LY; Sigma) in
100 mM sodium acetate (pH 4.5) was added to the solution, the
reaction mixture was wrapped with foil to exclude light, and the
mixture was stirred gently for 18 h at room temperature. The product,
LY-GDEVDGVK, was puri¢ed by preparative HPLC (Gilson, Mid-
dleton, WI, USA) with an octadecylsilica (ODS) column (GL Scien-
ces, Tokyo, Japan). Lyophilized LY-GDEVDGVK was dissolved in
300 Wl of 100 mM sodium acetate, and 2.1 mg (4.0 Wmol) of 5-carbox-
ytetramethylrhodamine succinimidyl ester (CTMR-SE, synthesized in
two steps from N,N-dimethylaminophenol and trimellitic anhydride)
in 50 Wl of CH3CN was added. After 30 min, LY-GDEVDGVK-
CTMR was puri¢ed by preparative HPLC. MALDI-TOF MS m/z
1715 (theoretical MH = 1715).
CDCF-GDEVDGVK-CTMR and CDCF-GDEVDGVK-CXR
were synthesized by the same method as LY-GDEVDGVK-CTMR,
except for the usage of 6-carboxy-2P,7P-dichloro£uorescein hydrazide
(CDCF, synthesized based on the literature [9]) and 5-carboxy-X-
rhodamine succinimidyl ester (CXR-SE, synthesized in two steps
from 8-hydroxyjulolidine and trimellitic anhydride) instead of LY
and CTMR-SE. MALDI-TOF MS m/z 1730 (theoretical MH of
CDCF-GDEVDGVK-CTMR = 1729), 1832 (theoretical MH of
CDCF-GDEVDGVK-CXR = 1833), respectively.
2.3. Protease assay
Fluorometric substrates (4 WM) were incubated with 10 ng of re-
combinant caspases for 1 h at 37‡C in 50 Wl of PA bu¡er. Then, 450 Wl
of cold water was added to the reaction mixtures and the £uorescence
intensity was measured. Excitation and emission wavelengths of LY-
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GDEVDGVK-CTMR, CDCF-GDEVDGVK-CTMR (and CDCF-
GDEVDGVK-CXR) and DEVD-MCA are 430 nm/530 nm, 505
nm/525 nm and 380 nm/460 nm, respectively.
2.4. Cell culture and induction of apoptosis
HeLa-S3 cells were cultured in Dulbecco’s modi¢ed Eagle’s medium
(DMEM) supplemented with 100 Wg/ml kanamycin and 10% fetal
bovine serum at 37‡C in a humidi¢ed atmosphere of 5% CO2/95% air.
The cells were treated with etoposide (20 Wg/ml) to induce apopto-
sis. After 24 h, the cells were harvested, washed twice with PBS, and
lysed in lysis bu¡er (10 mM HEPES (pH 7.4), 5 mM dithiothreitol,
2 mM EDTA, 0.1% CHAPS). This lysate (50 Wg protein) was incu-
bated at 37‡C with 4 WM of each synthetic £uorometric probe or
DEVD-MCA in PA bu¡er. The total volume of the reaction mixture
was 50 Wl. After incubation for 2 h, 450 Wl of cold water was added to
the reaction mixture and the £uorescence intensity was measured.
2.5. Microinjection
HeLa-S3 cells were grown on a poly-D-lysine-coated glass-bottomed
dish (MatTek, Ashland, MA, USA). CDCF-GDEVDGVK-CTMR
(200 WM) was dissolved in microinjection bu¡er (10 mM Tris, pH
7.4, 25 mM KCl), and injected into the cells with an Eppendorf in-
jection system attached to an Olympus IX70 microscope. Each cell
was injected for 0.1 s at a pressure of 100 hPa. After the injection, the
cells were incubated for 7 h in a CO2 incubator for stabilization.
2.6. Microscopic visualization of caspase activation
The injected cells were observed with a £uorescence microscopic
imaging system, Argus 50 (Hamamatsu Photonics, Shizuoka, Japan),
with MBP490, DM505 and BA515IF ¢lter units. After post-incuba-
tion, the injected cells were washed twice with PBS and suspended in
Hanks’ balanced salt solution (pH 7.4) containing 1% fetal bovine
serum warmed at 37‡C. The dish was transported to the microscope
and the cells were treated with 10 Wg/ml etoposide. The £uorescence
images were captured at intervals of 10 min for 14 h.
3. Results
3.1. Design and synthesis of £uorescent probes for detecting
caspase activity
It is known that PARP is cleaved by caspase-3-like pro-
teases (group II caspases) during apoptosis and the cleavage
site sequence is -GDEVDGV- [2]. Using an oligopeptide con-
taining -GDEVDGV-, we designed novel £uorescent probes
to detect the activities of caspase-3 and its related caspases
(Fig. 1A). Two di¡erent £uorophores were conjugated to the
two terminals of the oligopeptide: one £uorophore (called the
donor) was conjugated to the N-terminus of the oligopeptide,
and the other (called the acceptor) to the C-terminus. LY and
CDCF were chosen as donors, and CTMR and CXR as ac-
ceptors, based on their spectral characteristics (Fig. 1B).
When we measured the £uorescence spectra of these com-
pounds, the emissions of the donors were highly quenched.
Presumably the acceptor absorbs the donor’s energy, because
Fig. 1. A: Structure of the synthetic £uorometric probes and mecha-
nism of detection of caspase-3. B: Structures of the £uorophores
used as donors and the acceptors. GDEVDGVK is Gly-Asp-Glu-
Val-Asp-Gly-Val-Lys.
Fig. 2. Emission spectra of the synthetic £uorometric probes before
(open circles) and after (closed circles) incubation with recombinant
human caspase-3. A: LY-GDEVDGVK-CTMR. B: CDCF-
GDEVDGVK-CTMR. C: CDCF-GDEVDGVK-CXR. All synthetic
probes (2 WM) were incubated with recombinant human caspase-3
(0.2 Wg/ml) for 4 h at 37‡C.
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the conformation of the peptide in aqueous solution would
allow the donor and acceptor to be in close proximity. Strong
£uorescence was expected to be generated after cleavage of the
peptide, since the donor and acceptor would no longer be
adjacent.
When the three double-labeled peptides were incubated
with recombinant human caspase-3, the £uorescence intensity
of all the donors increased greatly (Fig. 2). These increases
were completely inhibited by addition of Z-Asp-CH2-DCB
[10], which is an irreversible caspase inhibitor (data not
shown). Then we examined whether these compounds were
cleaved by other recombinant human caspases (caspase-1,
-6, and -7). Caspase-7, which belongs to the same family as
caspase-3 [1], cleaved them as e¡ectively as caspase-3, while
caspase-1 and caspase-6 showed little activity (Fig. 3). When
DEVD-MCA was incubated with caspase-6 under the same
conditions, the £uorescence intensity reached about 60% of
that obtained with caspase-3 (data not shown).
3.2. Detection of caspase-3 activity from apoptotic cells
Etoposide is a topoisomerase II inhibitor that induces
apoptosis in various cell lines [11]. We stimulated HeLa-S3
cells with etoposide to induce apoptosis and prepared the
cell lysate. To test whether it is possible to detect caspase-3-
like activity using the synthetic £uorometric probes, the
probes were incubated with the cell lysate. All the £uoromet-
ric probes were cleaved when they were incubated with cell
lysate prepared from apoptotic cells, and most of the proteo-
lytic activity was suppressed by adding Z-Asp-CH2-DCB to
the reaction mixture (Fig. 4). Moreover the background £uo-
rescence intensity, due to cleavage by other intracellular pro-
teases, was much smaller than the background of DEVD-
MCA. The results suggested that these probes can be used
to detect caspase-3-like activity in living cells under a mi-
croscope. The £uorescence of another synthetic probe, LY-
AYVHDAPVK-CTMR, which was designed as a £uorometric
probe to detect caspase-1 activity, was not increased by incu-
bation with etoposide-treated cell lysate as compared to the
control. We could also detect caspase-3-like activity from
apoptotic THP-1 cells with the synthetic probes (data not
shown).
Fig. 3. Fluorescence intensity of the synthetic £uorometric probes
after incubation with several caspases. All synthetic probes were in-
cubated with 0.2 Wg/ml of recombinant human caspases (-1, -3, -6
and -7) at 37‡C. After 1 h, the reaction mixtures were diluted 10-
fold with cold water, and the £uorescence spectra were measured.
Relative £uorescence value is expressed as a percentage of the con-
trol £uorescence value in the absence of enzyme.
Fig. 4. Detection of caspase-3-like activity from HeLa-S3 cells
treated with etoposide by using the synthetic £uorescent probes. All
synthetic probes and DEVD-MCA were incubated for 2 h at 37‡C
with cell lysates of HeLa-S3 cells untreated (control) or treated with
20 Wg/ml etoposide for 24 h. Z-Asp-CH2-DCB was added at
100 WM. Relative £uorescence is expressed as a percentage of con-
trol values. GDEVDGVK and AYVHDAPVK are Gly-Asp-Glu-
Val-Asp-Gly-Val-Lys and Ala-Tyr-Val-His-Asp-Ala-Pro-Val-Lys, re-
spectively.
Fig. 5. Fluorescence images of CDCF-GDEVDGVK-CTMR-in-
jected HeLa-S3 cells A: 2 h, B: 4 h, C: 6 h, D: 8 h, E: 10 h and
F: 12 h after treatment with 10 Wg/ml etoposide. Arrows show the
cell membrane blebs. The cells were incubated at 37‡C under hu-
midi¢ed air. Five cells are numbered 1^5 as shown in A.
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3.3. Microscopic visualization of caspase-3-like activity in
living HeLa-S3 cells
To examine the feasibility of microscopic visualization of
caspase-3-like activity, CDCF-GDEVDGVK-CTMR was mi-
croinjected into HeLa-S3 cells. The injected cells were treated
with etoposide after post-incubation, and the £uorescence im-
ages of the donor were captured at intervals of 10 min for 14
h. Green £uorescence of the donor gradually increased from
about 5 h after the treatment with etoposide (Fig. 5). The
increase of the £uorescence was initially observed in the cyto-
sol, then the caspase-3-like activity was observed through the
whole cell including the nucleus.
In some of the cells, the £uorescence intensity decreased
rapidly after the increase. When untreated cells were observed
with the £uorescent probe, the £uorescence of the donor
hardly increased as compared with the treated cells.
4. Discussion
Caspases have very important roles in the apoptotic proc-
ess, and caspase-3 and its related caspases such as caspase-2
or -7 cleave many proteins related to apoptosis [2,5,12^15].
Therefore, observation of temporal and spatial changes of
caspase-3 activity in the cell with ¢ne resolution is important
to clarify the mechanism of apoptosis. We considered that
imaging of caspase-3 would be one of the best approaches.
DEVD-MCA and its derivatives are widely used in experi-
ments to measure caspase-3-like activity, but they cannot be
applied to imaging of living cells, because their excitation
wavelength is short in the UV region. In this paper, we syn-
thesized novel synthetic £uorometric probes, double £uores-
cence-dye-labeled peptides, which were superior to DEVD-
MCA with regard to speci¢city and sensitivity. All these syn-
thetic £uorometric probes were excited at long wavelength in
the visible region, and should be suitable for imaging experi-
ments with low background £uorescence.
We chose dichloro£uorescein as a £uorophore (donor) for
the synthetic probes, because it has a high £uorescence quan-
tum yield, it is excited at long wavelength and it is very stable.
Dichloro£uorescein has a lower pKa value than £uorescein,
and its £uorescence intensity is independent of the solvent pH
at around neutral pH. Tetramethylrhodamine and X-rhod-
amine were chosen as acceptors because their absorbance
spectra overlap with the emission spectrum of dichloro£uo-
rescein. Lucifer yellow was chosen as another donor because
its emission maximum (530 nm) is similar to that of dichloro-
£uorescein (525 nm).
We initially designed these £uorescent probes based on the
principle of £uorescence resonance energy transfer (FRET).
FRET is a phenomenon that can be observed when the donor
is near (6 about 100 Aî ) the acceptor [16]. When FRET oc-
curs, the £uorescence of the donor is absorbed by the acceptor
and the £uorescence of the acceptor is observed. However,
when the synthetic probes were excited in aqueous solution,
the acceptor’s £uorescence was not observed, even though the
donor’s £uorescence was absorbed, except in the case of LY-
GDEVDGVK-CTMR. Since FRET was observed when the
probes were dissolved in methanol, we assume that the donor
and the acceptor did not interact with each other in methanol
because methanol is less polar than water, and in an aqueous
solution the £uorescence of the acceptor was not observed
because the donor and the acceptor interacted intramolecu-
larly in a hydrophobic manner.
When the synthetic probes were incubated with recombi-
nant human caspase-3, the £uorescence intensities of the do-
nors increased, as expected (Fig. 2). To preclude the possibil-
ity that the synthetic probes were cleaved by other caspases
such as caspase-6, the probes were mixed with other caspases.
These double-labeled probes were hardly cleaved by caspase-
6, although DEVD-MCA was cleaved by caspase-6. Accord-
ingly, these synthetic probes are superior to DEVD-MCA for
detecting caspase-3-like activity in living cells. However, the
synthetic probes were also cleaved by caspase-7, which be-
longs to the same group as caspase-3.
Since we could detect caspase-3-like activity in the lysate of
HeLa-S3 cells treated with etoposide (Fig. 4), we tried to
image caspase-3-like protease activity in apoptotic HeLa-S3
cells. Because none of the synthetic probes was membrane-
permeable, we used a microinjection technique. We chose
CDCF-GDEVDGVK-CTMR for this experiment because it
is excited at a longer wavelength (ex. 505 nm) and has a high-
er £uorescence intensity than LY-labeled compounds (ex. 430
nm).
When the £uorescence images of CDCF-GDEVDGVK-
CTMR in etoposide-treated HeLa-S3 cells were captured
(Fig. 5), an increase of the £uorescence appeared from about
5 h after the treatment with etoposide. After 8 h, blebbing of
the cell membrane was observed and the number of the blebs
was increased at 10 h and 12 h (cells 1, 2 and 4 in Fig. 5), then
the cells died. This result provides direct evidence that bleb-
bing of the cell membrane follows activation of caspase-3-like
proteases. The £uorescence intensity was initially augmented
outside the cell nucleus, and in the second step the intensity
was expanded to the whole cell including the nucleus (cells 2^
5). When the activity was observed through whole cells, the
£uorescence intensity in the nucleus was apparently higher
than in the cytosol, compared with the nuclear pattern of
the Hoechst dye staining images. In order to con¢rm that
the cleaved product (CDCF-GDEVD) does not localize to
the nucleus, we injected it into the cells. The distribution of
the cleaved product did not change after 6 h. However, it is
necessary to con¢rm under confocal microscopy for the deter-
mination of nuclear activity, because the thickness of the cell
around the nucleus does a¡ect the £uorescence intensity under
this condition.
Moreover, the £uorescence of some cells decreased rapidly
after the gradual increase. The reason for this decrease is
presumed to be that when the cells died of apoptosis, the
cell membrane was fractured and the probes leaked out into
the medium. The £uorescence of cell 1 decreased after the
capture of Fig. 5F. In another experiment, the degradation
of the nucleus was observed when the cells start to bleb.
In conclusion, we could image the intracellular activity of
caspase-3-like proteases under a £uorescence microscope by
using a new £uorescent probe. It should be possible to extend
this method to measure protease activity in various biological
samples, for instance, neuronal tissues, nematodes, etc.
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